You just read:

BeyondSpring Announces First Patient Enrolled in Phase 1b/2 Investigator-Initiated Trial of Plinabulin plus Nivolumab for Non-Small Cell Lung Cancer

News provided by

BeyondSpring Pharmaceuticals

27 Sep, 2016, 08:15 ET